June 30, 2020
Webinar: Achieving Diversity and Inclusion in Clinical Trials
Clinical trials should be accessible to the population suffering from the illness. However, underrepresentation in clinical trials by racial and ethnic minorities continues to be a multi-layered problem.
Cassandra Smith, Director of Diversity and Inclusion in Clinical Trials Lead, Janssen R&D looks at why a changing global population requires more clinical trial diversity for the future of drug development and what role sponsors can play to make trials more accessible to all patients.
Cassandra originally presented this segment in a longer webinar addressing clinical trial inclusion and diversity titled "No One Left Behind: Addressing Clinical Trial Access and Issues Blocking Physician Participation."